2m 2m 2m 2m 2m 2m 2m
CENTURY THERAP (IPSC)
NASDAQ
$1.76+$0.08 (+4.70%)
Price as of Nov 11, 2026 7:42 AM EST- $304.2MMarket Cap
- 198.24%1-Year Change
- BiotechnologyIndustry
CENTURY THERAP (IPSC)
$1.76+$0.08 (+4.70%)
IPSC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.68 | ||
Change | -$0.13 (-7.18%) | ||
Open | $1.77 | ||
High | $1.85 | ||
Low | $1.63 | ||
Previous Close | $1.81 | ||
Volume | 720,026 | ||
30-Day Average Volume | 998,094 | ||
1-Week Change | 10.53% | ||
1-Month Change | 14.29% | ||
1-Year Change | 198.24% | ||
3-Year Change | 30.23% | ||
5-Year Change | -92.00% | ||
Fundamentals | |||
Shares Outstanding | 181.1M | ||
Total Assets | $287.0M | ||
Market Cap | $304.2M | ||
Enterprise Value | $254.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$34.5M | ||
Free Cash Flow | -$20.5M | ||
EBIT | -$34.5M | ||
EBITDA | -$31.9M | ||
Net Working Capital | $109.7M | ||
EPS | -$0.17 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue